Robert Popovian, PharmD
Chief Science Policy Officer, Global Healthy Living FoundationSenior Fellow of Health Policy, Progressive Policy Institute
Visiting Health Policy Fellow, Pioneer Institute for Public Policy Research.
Recent Work
-
PBMs Are Inflating the Cost of Generic Drugs. They Must Be Reined In
Anti-competitive practices and a lack of transparency in the generic drug market allow pharmacy benefit managers to profit off patients and payers.
Categorized in -
U.S. Consumers Overpay for Generic Drugs
Tactics used by intermediaries in the pharmaceutical distribution system, including pharmacy benefit managers (PBMs) and insurers, are costing patients, employers and the government billions for what should be inexpensive medicines.
Categorized in -
Is the U.S. Ready to Quickly Vaccinate its Population Against COVID-19?
Once a COVID-19 vaccine is developed, achieving universal immunization will require a cohesive, multi-faceted vaccination strategy across the U.S. healthcare system.
Categorized in